# Preclinical Research of mμSORS for Noninvasive Blood Glucose Detection

Study · id `cardio:ct-nct05921344` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05921344](<https://clinicaltrials.gov/study/NCT05921344>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05921344

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 200 participants.

## Technical summary

Registry record NCT05921344. Allocation not applicable; no masking; primary purpose diagnostic. Start 2023-07-11 (actual); primary completion 2023-09-19 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 200 participants (enrolled count; ClinicalTrials.gov record NCT05921344, source copy `cardio:ctgov-nct05921344-2025-02-05`, retrieved 2026-10-26)
- Started: 2023-07-11 (actual) (ClinicalTrials.gov record NCT05921344, source copy `cardio:ctgov-nct05921344-2025-02-05`, retrieved 2026-10-26)
- Primary completion: 2023-09-19 (actual) (ClinicalTrials.gov record NCT05921344, source copy `cardio:ctgov-nct05921344-2025-02-05`, retrieved 2026-10-26)
- Completion: 2023-10-10 (actual) (ClinicalTrials.gov record NCT05921344, source copy `cardio:ctgov-nct05921344-2025-02-05`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT05921344, source copy `cardio:ctgov-nct05921344-2025-02-05`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05921344-2025-02-05`, retrieved 2026-10-26)

## The registry's words

- Brief title: Preclinical Research of mμSORS for Noninvasive Blood Glucose Detection
- Condition: Type 2 Diabetes
- Condition: Medical Device
- Intervention (Device): Multi-channel Microspatial Offset Raman Scattering Spectroscopy (mμSORS) for Noninvasive Blood Glucose Detection
- Lead sponsor: Shanghai Jiao Tong University School of Medicine
- Lead sponsor class: OTHER
- Collaborator: Shanghai Photonic View Technology Co., Ltd.
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: Shanghai Jiao Tong University School of Medicine (`cardio:org-shanghai-jiao-tong-university-school-of-medicine`)

## Provenance

Content hash: 1df096b9af74f1f00ffaf5a2f50a436617a71a230cd9b865178c2e0fa30f9cf3
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
